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Abstract
Background: Treatment of end stage renal disease has an impact on patients’ physical and psychological health,
including quality of life (QoL). Nowadays, it is known that reducing the dialysis period has many advantages
regarding QoL and medical outcomes. Although preemptive transplantation is the preferred strategy to prevent
patients undergoing dialysis, its psychological impact is unknown. Moreover, transplantation can be experienced
in a completely different manner among patients who were on dialysis and those who still had a functioning
kidney at the time of surgery. Longitudinal data are often collected to allow analyzing the evolution of patients’
QoL over time using questionnaires. Such data are often difficult to interpret due to the patients’ changing standards,
values, or conceptualization of what the questionnaire is intended to measure (e.g. QoL). This phenomenon is referred
to as response shift and is often linked to the way the patients might adapt or cope with their disease experience.
Whether response shift is experienced in a different way among patients who were on dialysis and those who still had
a functioning kidney at time of surgery is unknown and will be studied in the PreKit-QoL study (trial registration
number: NCT02154815). Understanding the psychological impact of pre-emptive transplantation is an important
issue since it can be associated with long-term patient and graft survival.
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Methods/Design: Adult patients with a pre-emptive transplantation (n = 130) will be prospectively included
along with a control group of patients with a pre-transplant dialysis period < 36 months (n = 260). Only first
and single kidney transplantation will be considered. Endpoints include: comparison of change between
groups in QoL, anxiety and depressive disorders, perceived stress, taking into account response shift. These
criteria will be evaluated every 6 months prior to surgery, at hospital discharge, at three and six months, one
and two years after transplantation.
Discussion: The PreKit-QoL study assesses and compares the evolution of QoL and other psychological criteria in
preemptive and dialyzed patients taking patients’ adaptation into account through response shift analyses. Our study
might help to conceive specific, adapted educational programs and psychological support to prevent a possible
premature loss of the kidney as a consequence of non-compliance in patients that may be insufficiently prepared
for transplantation.
Trial registration: ClinicalTrials.gov identifier NCT02154815, registered on May 28, 2014
Keywords: Tansplantation, Nephrology, Preemptive, Dialysis, Quality of Life, Response shift, Item Response
Theory, Structural Equation Modeling
Background
End stage renal disease, dialysis and transplantation
Chronic kidney disease can lead to end stage renal
disease (ESRD), which requires use of substitution
techniques such as hemodialysis, peritoneal dialysis or
kidney transplantation. Treatment of ESRD is cum-
bersome in terms of implementation, impact on the
physical and psychological health of patients, quality
of life (QoL) and it generates substantial health ex-
penditures. It is well-known that kidney transplantation in
eligible ESRD patients is the treatment of choice com-
pared to long-term dialysis [1] since it is associated with
longer survival [2]. Furthermore, the cost of transplant-
ation is lower as compared to dialysis. Some studies have
also described higher QoL for kidney transplant recipients
compared to patients undergoing dialysis [3, 4] as well as
more positive perceptions of illness when changing from
dialysis to transplantation [5]. Hence, limiting the dialysis
period before transplantation has several advantages in
terms of medical outcomes, QoL and costs. In respect
with the same arguments, one can expect that preemptive
transplantation, i.e. the patient is placed on the transplant
waiting list and transplanted prior to progression to ESRD,
would be the preferred strategy. Nevertheless, the litera-
ture does not provide a clear answer regarding the benefit
of preemptive transplant and even less is known about its
psychological impact and its possible burden for patients:
for instance, patients may not be aware of the benefit of
transplantation compared to dialysis but in contrast may
suffer from the consequences of transplantation. Although
it is recommended to enlighten patients of all possible
consequences and complications after the transplantation,
patients are sometimes anyway startled since for instance
they suffer after the surgery, or are uncomfortable with
the load of the immunosuppressive therapy. Furthermore,
in transplantation centers, it has been observed that
patients receiving a preemptive transplant may con-
sider or perceive transplantation as an event that has
deteriorated their well-being [6].That may explain the
high variability of preemptive transplant practice
worldwide [7]. This lack of data regarding the psycho-
logical impact of preemptive transplantation consti-
tutes a true issue since these subjective outcomes can
be associated with the long-term patient and graft
survival [8]. This issue is important regarding the col-
lective impact of early registration on waiting list:
preemptive transplantations are associated with an in-
crease in the duration on waiting lists, which remains
an important risk factor of graft failure. In fact, no
data allows concluding on post-transplant QoL in par-
ticular because transplantation can be experienced in
a completely different manner among patients who
were on dialysis and those who still had a functioning
kidney at the time of surgery.
Psychological impact of dialysis and transplantation
Studies assessing the psychological impact and QoL of
Patients with Preemptive Transplantation (PPT) com-
pared with Patients with Dialysis before Transplant-
ation (PDT) are lacking and it cannot be assumed that
preemptive transplantations systematically improve pa-
tients’ QoL. Indeed, if few disease limitations and
symptoms were experienced before transplantation, the
aftermath of the graft may seem disproportionate, espe-
cially in case of post transplantation complications (in-
fection, acute rejection, etc.). Moreover, these patients
in ESRD who are not on dialysis have to simultaneously
be psychologically prepared for dialysis and transplant-
ation, without knowing which of the two treatments
they will have to face first. Some patients may prepare
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for dialysis and then be referred for a transplant in-
stead, for which they are not ready. In contrast, other
patients might await transplantation and perceive dialy-
sis as a failure. In this setting, a better understanding of
how patients anticipate, live and face pre and post-
transplantation and its consequences can contribute to
enhance and better orientate educational programs to
improve patient care.
Longitudinal data and response shift
The importance of studying longitudinal evolution of
perceived QoL of patients with chronic disease and in
identifying its possible associated factors is now well
admitted [9–11]. Such QoL data are often collected
through questionnaires including different items called
Patient-Reported Outcomes (PRO). Despite the fact
that PRO are nowadays considered simple, valid and
reliable measures of QoL, it is however clear that the
cognitive processes involved in completing them are
quite complex [12] and that longitudinal PRO data
might sometimes be very difficult to interpret. Indeed,
some studies have evidenced a stable or even a higher
level of perceived Qol in patients with severe chronic
conditions, despite a poor physical health state, as
compared to the general population [13–15]. By contrast,
others have shown opposite results for stable patients, re-
garding their health status across occasions, reporting
changes in QoL. This phenomenon, which might be
regarded as a paradox, is sometimes referred to as re-
sponse shift (RS) [16, 17]. In case of RS, there is a change
in the meaning of what the PRO (QoL, anxiety, pain, etc.)
is intended to measure over time or in the patient’s expec-
tations and life priorities according to the disease evolu-
tion. It is often linked to the way the patients might adapt
or cope with their disease experience. RS can result from
three different processes [16, 17]: 1) changes in the pa-
tient’s internal standards of measurements called recali-
bration (i.e. the level of QoL or anxiety measured by the
questionnaire can be interpreted differently before and
after transplantation), 2) changes in the patient’s values
and in the relative importance given to the questions or
dimensions of QoL that are appraised before and after
transplantation, called reprioritization, and 3) changes in
the patient’s definition of what is being measured over
time called reconceptualization. Hence, it might be prob-
lematic or even impossible to distinguish, without appro-
priate methods, true QoL changes from confounding RS
effects. Indeed, patients may give different answers to the
PRO over time, not only because their health has changed,
but also because their perception on what health or QoL
means to them has changed. The accurate assessment of
the effect of transplantation for instance can then be ob-
fuscated by RS and lead to biased results, poor power to
detect effects of interest and therefore, erroneous
conclusions [18–21]. Indeed, RS can seriously alter the
psychometric properties of PRO such as reliability, val-
idity and ability to detect true changes (responsiveness)
[22]. On the other hand, one can also highlight the
therapeutic importance that the phenomenon of RS
constitutes in itself by allowing a better understanding
of how patients adjust to their illness. RS may well also
be one of the goals of therapy in helping patients to
cope with their illness and to live with it. Therefore, RS
can be viewed either as a nuisance (measurement bias)
or as an indication of a possible therapeutic benefit
coming from some form of psychological adaptation or
adjustment. In fact, it is very likely that the post-
transplant QoL experienced by patients for whom first
replacement therapy was transplantation might be
lower than for patients who have undergone dialysis,
even for a short period of time [1, 23]. The rigorous
comparison of change in the QoL of preemptive kidney
transplant patients and patients who were on dialysis
requires taking into account the very likely occurrence
of the RS phenomenon, not only in terms of detection,
but also in terms of statistical adjustment in the ana-
lysis of changes in PRO data.
Aims and objectives
Our hypothesis is that preemptive kidney transplant re-
cipients have a lower quality of life and present more
difficulties regarding psychological adaptation after
transplantation compared to patients who were under
dialysis before surgery for less than 3 years. The de-
signed project aims at providing a better assessment and
understanding of the psychological impacts and of pa-
tients’ psychological adaptation, taking into consider-
ation the response shift, as well as patient and graft
outcomes following preemptive transplantation. This
could help optimizing the management of these patients,
particularly regarding therapeutic education programs
and adapted implementation of psychological support.
Methods/Design
Study design
The PreKit-QoL study is a prospective, multicenter,
controlled study of quality of life, psychological ad-
justment process and medical outcomes of patients
receiving a preemptive kidney transplant (PPT group)
compared to a similar population of recipients after a
dialysis period of less than three years (PDT group).
The clinical and psychological data as well as the
QoL questionnaires will be prospectively collected in
the PPT and the PDT groups. Both groups will be
matched regarding the recipient gender and the trans-
plantation centers which are the two parameters dif-
ferentially distributed between the two groups in our
prospective cohort DIVAT (www.divat.fr). The type of
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donors (deceased or living) will be also matched be-
tween PDT and PPT. Since it is important to assess
QoL before transplantation in order to evaluate re-
sponse shift related to transplantation, the question-
naires will be collected for all patients waiting a first
transplantation without dialysis or with a dialysis
period of less than 36 months. Data will be collected
at transplantation (sex, age, immunization, medical
history, etc.). Other data that change over time, such
as QoL, will also be collected every six months before
transplantation, at hospital discharge, and 3, 6, 12
and 24 months after transplantation. The flowchart of
the study is presented in Fig. 1.
Study setting and participants
Patients will be mainly recruited from the University
Hospital centers participating in the DIVAT network
(Données Informatisées et VAlidées en Transplant-
ation, 6 centers in France: Nantes, Paris Necker, Paris
Saint-Louis, Nice, Lyon). The University Hospitals of
Marseille and Toulouse will also participate in the
study. The duration of inclusion will be four years.
Data collection will take place over six years including
the 2-year follow-up of the last included patient. In
total, the study will take place over a period of seven
years to allow for data analysis. It is a non-interventional
research study (routine care), all investigators have agreed
to provide patients with clear and precise information
about the protocol and will give a copy of the information
form to the patients. The patient will be enrolled in the
study after reading the information form and signing and
dating it. Both documents will be issued in duplicate hard
copy format so that the patient and the investigator can
each keep a copy. The investigator’s original will be placed
in the investigator’s file.
Inclusion criteria
All patients will be over 18 years old without being
under guardianship. All patients with a preemptive
transplantation from deceased or living donors will be
Fig. 1 Flowchart of the PreKiT-QoL study. Mx: x months after transplantation, x = 3, 6, 12, and 24
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prospectively included in the PreKit-Qol study. Only
first kidney transplantations without other transplanted
organ will be considered.
Primary outcome measure
The primary outcome will be the change in QoL,
taking into account the possible occurrence of re-
sponse shift. This criterion will be measured by a
specific questionnaire ReTransQol developed for kidney
transplant recipients [24]. It will be evaluated every
6 months prior to surgery, at hospital discharge, and three
months, six months, one year and two years after the
transplantation.
Secondary outcome measures
The following outcomes will be compared between PPT
versus PDT:
 The change in generic QoL, subjective well-being,
perceived anxiety and depressive disorders as well
as perceived stress during follow-up (every 6 months
before the surgery, at hospital discharge, 3, 6, 12, and
24 months post-transplantation) taking into account
the possible occurrence of response shift. Generic
QoL will be assessed with the SF-36 questionnaire.
This questionnaire has the disadvantage of not being
specific, and therefore less sensitive to specific
changes in the health status of the recipient.
However, it allows a comparison of the results to
a reference population [25] and allows an easier
comparison of the patients in different therapeutic
frameworks (for example patients before and after
transplantation). Subjective well-being, anxiety and
depressive disorders, and perceived stress will be
assessed using the satisfaction with life scale
(SWLS) [26, 27], the Hospital Anxiety and Depression
scale (HAD) [28, 29], and the Perceived Stress Scale
(PSS) [30], respectively.
 Coping strategies (process of managing stressful
circumstances) and post-traumatic growth (positive
psychological change experienced as a result of the
struggle with highly challenging life circumstances)
at 6 and 24 months post-transplantation. Coping
strategies and post-traumatic growth will be
assessed using with the Brief Cope [31] and the
Posttraumatic Growth Inventory (PTGI) [32],
respectively.
 The post-transplantation graft and patient outcomes
collected at hospital discharge, and 3, 6, 12 and
24-months post-transplantation: i) evolution of
the Graft Filtration Rate (GFR) that will be
estimated using the 4-variables MDRD formula
[33], ii) evolution of the daily proteinuria that
will be diagnosed by a simple dipstick test.
 The Kidney Transplant Failure Score at one year
post-transplantation [34]. The KTFS is able to
predict death-censored graft survival.
 The post-transplantation time to return to work, if
appropriate.
 The compliance of patients will be assessed every
six months prior to surgery, at hospital discharge,
and at 3, 6, 12, and 24 months with the Girerd
questionnaire [35].
In addition, other collected clinical data as well as vari-
ables related to the social status of the recipient are
given in Table 1. The schedule of the study is presented
in Table 2.
Sample size
Computation of a minimum required sample size is not
statistically feasible for this study based on the observa-
tion of perceived QoL and psychological data taking into
account the possible occurrence of RS. Indeed, the con-
cept of RS is complex and novel in this disease and we
have no preliminary data or any clear expectation for the
results. The sample size will therefore be driven by the
inclusion capacities of each center involved in the
PreKiT-QoL study. Based on the extraction of the
DIVAT data bank of the recipients transplanted between
2010 and 2012, one can expect that at least 130
Table 1 Clinical variables directly extracted from the DIVAT data bank
Recipient Age, gender, weight, height, clinical center, initial disease (glomerulonephritis, diabetes, etc.),
cold ischemia time, HLA A-B-DR incompatibilities, number of post transplantation dialyses,
pre-transplantation anti HLA immunization whatever the technique used within the six months
prior to surgery, cardiovascular history, cancer history, hypertension history, diabetes history, pre
transplantation dialysis technique, previous educational program.
Donor Age, gender, last serum creatinine level, cause of death, hypertension history.
Dates Birth, first dialysis, registration on waiting list, transplantation, acute rejection episodes, return
to work, return in dialysis, last follow-up, death.
The biological follow-up at hospital discharge, three,
six, 12 and 24 months
The creatininemia (1) and the daily proteinuria.
(1). The creatininemia will also be collected before the surgery in order to adjust our analysis on the renal function: the psychological impact of the
transplantation may depend on the previous grade of renal insufficiency
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recipients with preemptive transplantation (case) can be
included during the four years inclusion period of the
protocol. For each case, two control recipients who have
experienced a pre-transplant dialysis period of less than
36 months will be included matched on gender, trans-
plant center, and type of donor. A total of 390 patients
will be included. This ratio 1:2 has been chosen to in-
crease the sample size and the statistical power, the main
expected limitation being the inclusion of patients re-
ceiving preemptive transplantation.
Statistical analysis
Recipients will be described according to both groups,
PPT and PDT. Such descriptive analyses will be per-
formed on the main socio-demographic and clinical
variables, either related to the recipient (except for the
gender which is a matched between both groups), the
donor or the transplantation. Categorical variables will
be compared using Mac Nemar Chi2 tests for matched
data. Continuous variables will be compared using a
Student’s t-tests for paired data. This step will be im-
portant to assess the heterogeneity of the two popula-
tions and to identify possible confounding factors.
Structural equation models (SEM) and models coming
from Item Response Theory (IRT) will be used to
analyze changes in QoL and psychological dimensions
(subjective well-being, perceived anxiety and depressive
disorders, perceived stress) including the detection of re-
sponse shift (RS) occurrence and its adjustment in the
analyses, where appropriate, to estimate true changes.
SEM and IRT will be used as complementary methods
since SEM is appropriate for detecting RS at the dimen-
sion level (e.g. the “Physical Health” dimension of the
RetransQoL) and IRT is appropriate for detecting RS at
the item level within a dimension (e.g. the item “You are
as well as anyone else” in the “Physical Health” dimen-
sion of the RetransQoL). SEM models [36] often include
variables that are not directly observed (latent variables
corresponding to QoL dimensions for instance) and
possible links between these and the observed variables
(observed scores for each QoL dimension). IRT models
belong to the family of generalized linear random ef-
fects models [37]. They describe the probability of
responding to each response category of a given item as
a function of the latent variable one is trying to meas-
ure (patient’s “true QoL”) taking into account the psy-
chometric characteristics of the scale through the
questionnaire’s items parameters. Identification of RS
and “true change” estimation (change in the subjective
criterion being studied taking RS into account) will be
performed in the following way: SEM analyses will follow
the iterative algorithm developed by Oort [38] and IRT
analyses will be done using a specific iterative algorithm
called the RespOnse Shift ALgorithm in Item response
theory (ROSALI) that has been recently developed [39].
Change in coping strategies and in post-traumatic
growth will be measured at 6 and 24 months after trans-
plantation and assessed using linear mixed models [40].
The GFR will be measured at hospital discharge, and 3,
6, 12, and 24 months post-transplantation and estimated
using the MDRD formula [33]. A linear mixed model
will also be used to handle these longitudinal measure-
ments. Three explicative variables will be systematically
taken into account: post-transplantation time, preemp-
tive transplantation (yes/no) and the interaction between
them. According to the non-linear relationship between
the post-transplantation time and the GFR evolution
[41], two slopes will be modeled with a breakpoint at
Table 2 Schedule of the PreKiT-QoL study
Activities Every six months before transplantation Hospital discharge M3 M6 M12 M24
Demographic data X
Previous medical history X
Transplantation data X
Donor data X
Creatininemia and proteinuria X X X X X
ReTransQol questionnaire X X X X X X
SF36 questionnaire X X X X X X
Satisfaction with Life Scale (SWLS) questionnaire X X X X X X
The Perceived Stress Scale (PSS) X X X X X X
The Brief Cope X X
The Hospital Anxiety and Depressions Scale (HAD) X X X X X X
The Post-Traumatic Growth Inventory (PTGI) X X
Compliance questionnaire X X X X X X
Kidney Transplant Failure Score (KTFS) X
X: collected data. Mx: x months after transplantation, x = 3, 6, 12, and 24X: collected data. Mx: x months after transplantation, x = 3, 6, 12, and 24
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6 months. For all linear mixed models, random terms
will be included on the intercept, on the slopes or
both. Univariate (p < 0.2) and multivariate (p < 0.05)
analyses will be performed in order to take into ac-
count possible confounding factors. The daily protein-
uria will be measured at hospital discharge, and 3, 6,
12 and 24 months post-transplantation. This random
variable is not Gaussian. A Gamma distribution is more
appropriate but since a generalized linear models with
such an inverse function as canonical link function will be
difficult to interpret, the proteinuria will be divided into
two classes for analysis: ≤0.5 g/24 h or >0.5 g/24 h.
A logistic model with random effects will therefore be
used [40]. The KTFS is a score that is computed at
one year. The mean score at one year will be com-
pared using a Student’s t-tests for paired data between
the PPT and PDT groups.
The statistical significance level will be set at 5 %
(type I error).
Missing data considerations
The difficulties in dealing with missing data are often
increased in the case of subjective data collected
using questionnaires because missing data are often
informative in this case. Indeed, we often observe that
as health deteriorates, the risk of non-responses in-
creases and missing data are therefore not random
(missing not at random or MNAR). The analysis of
MNAR data is truly problematic because it can lead
to biased and inaccurate estimates of RS and of the
true change of the subjective criteria one is trying to
assess [42, 43]. Yet, methods such as SEM assume
non informative missing data, that is to say missing
at random (MAR) or completely missing at random
(MCAR) data, unlike IRT models that can handle
non-random missing data. The interest of IRT models
was highlighted in cross-sectional and longitudinal
studies [44–47]. These models were more powerful
and allowed obtaining unbiased estimations of the ef-
fects of interest even in case of MNAR data, while
models based on the observed scores showed poor
properties in terms of bias and power estimates. The
potential of using models coming from IRT, instead
of or in addition to SEM models in the field of RS
was also emphasized from a conceptual point of view
[18, 48]. However, the formal assessment of the rela-
tive performance of SEM and IRT models in case of
missing data has never been done to our knowledge.
Hence, identification of the best methodological ap-
proach for RS detection in presence of missing data
is still unknown. As stated in the Statistical analysis
section, IRT and SEM will be used as complementary
analysis and they will be also used to perform sensi-
tivity analyses to assess the robustness of results.
Ethical approval and registration
The study is registered with the ClinicalTrials.gov Regis-
try (RC14_0078, NCT02154815), has approval from the
ethical Committee for Persons’ Protection (CPP, Tours,
2014-S8), and from the advisory committee on research
data and information in health (CCTIRS, Paris, 14.314).
Discussion
The main assumption of our study is that preemptive
kidney transplant recipients, who generally present a
better level of health than patients undergoing dialysis,
might although have a lower perceived quality of life and
have more difficulties in adapting themselves to their
new status. In contrast with the increasing number of
studies in cancer, exploration of response shift has, to
our knowledge, never been done in the context of ESRD
despite its relevance in this disease, particularly in the
context of preemptive transplantation. Our study will
give more insight on the adjustment processes at hand
in preemptive patients compared with patients with a
quite short period under dialysis. Thanks to this know-
ledge, it might then be useful to organize a therapeutic
educational program and psychological support specific-
ally adapted for these preemptive patients before and
following the transplant surgery. Exploration of the ex-
pectations of patients regarding transplantation could
help personalize the specific aims of educational pro-
grams. It could increase the level of preparedness for
transplantation and a better acceptance of its conse-
quences. This point would be of major importance to
prevent bad adherence to treatment if our results show
that preemptive patients “regret” being transplanted be-
cause they are possibly not enough prepared to this new
health status.
From a methodological point of view, the main limita-
tion of our study may be the possible lack of compar-
ability of the two groups that will be compared (PPT and
PDT) despite matching on gender, center, and type of
donor. To minimize this issue, all the statistical analyses,
including all response shift analyses, will try to take into
account confounding factors.
Conclusion
The PreKit-QoL study is the first study which directly
assesses the evolution of QoL and of other psychological
criteria like anxiety or perceived stress of patients receiv-
ing a preemptive transplant taking patients’ adaptation
into account through response shift analyses. We believe
that this work may help providing a fresh perspective on
expectations and care of transplanted patients, which
may provide support for future research, care and pre-
ventive actions in the field of kidney transplantation.
Our study might help to conceive specific and adapted
individual and collective educational programs and
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psychological support in order to prevent a possible
premature loss of the kidney as a consequence of
non-compliance in patients that may be insufficiently
prepared for transplantation.
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